Xininurad
Small moleculeexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Sep 30, 2019 (NCT04040907)
Timeline
2010s
- Jan 1, 2019
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
ABCG2 inhibitor
Chemistry & pharmacology
Loading structure…
SMILES
CCc1nc2ncc(F)cn2c1C(=O)c1cc(Br)c(O)c(Br)c1- Mol. weight
- 443.07 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL5314450 ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04040907 | Phase 1 | Sep 30, 2019 | Linear Clinical Research, Sinovent Pty Ltd. |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Linear Clinical Research | For profit | 1 | 0 | 1 | 2019 |
| Sinovent Pty Ltd. | For profit | 1 | 1 | 1 | 2019 |
2 organizations
Page 1 / 1